Effect of COVID-19 on Hip and Knee Arthroplasty Surgical Volume in the United States

Nicholas A Bedard, Jacob M Elkins, Timothy S Brown, Nicholas A Bedard, Jacob M Elkins, Timothy S Brown

Abstract

Background: In an effort to help combat the COVID-19 pandemic and preserve essential health care resources, starting in mid-March 2020, surgeons have been instructed to only perform essential surgical procedures. The vast majority of hip and knee arthroplasty surgery does not meet the definition of essential surgery. This study estimated the number of arthroplasty procedures that would be canceled because of these important restrictions.

Methods: The US hip and knee arthroplasty procedure volume projections for 2020 were estimated from four recently published studies. Data from the American Joint Replacement Registry were utilized to determine what percentage of these cases would be considered nonessential surgery. Monthly and weekly estimates of nonessential hip and knee arthroplasty procedures that would have occurred had there not been any restrictions due to COVID-19 were calculated.

Results: After excluding essential procedures, it was estimated that approximately 30,000 primary and 3000 revision hip and knee arthroplasty procedures will be canceled each week while COVID-19 restrictions regarding nonessential surgery are in place. If only 50% of nonessential cases were actually canceled across the United States, that would still result in the cancellation of 15,001 primary and 1435 revision hip and knee arthroplasty procedures per week while restrictions are in place.

Conclusion: This study highlights the profound impact COVID-19 is having on our current hip and knee arthroplasty volume. The large number of cases canceled because of COVID-19 translates into major financial losses for health care institutions and may have a profound impact on our patients.

Keywords: COVID-19; SARS-CoV-2; cancelation; total hip arthroplasty; total knee arthroplasty; volume.

Copyright © 2020 Elsevier Inc. All rights reserved.

References

    1. Sarac N.J., Sarac B.A., Schoenbrunner A.R., Janis J.E., Harrison R.K., Phieffer L.S. A Review of State Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak. J Bone Joint Surg Am. 2020;0:e1–e4. In press.
    1. Anoushiravani A.A., O’Connor C.M., DiCaprio M.R., Iorio R. Economic impacts of the COVID-19 crisis: an orthopaedic prespective. J Bone Joint Surg Am. 2020;0:e1–e5. In press.
    1. Sloan M., Premkumar A., Sheth N.P. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100:1455–1460.
    1. Singh J.A., Yu S., Chen L., Cleveland J.D. Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample. J Rheumatol. 2019;46:1134–1140.
    1. Inacio M.C.S., Paxton E.W., Graves S.E., Namba R.S., Nemes S. Projected increase in total knee arthroplasty in the United States - an alternative projection model. Osteoarthritis Cartilage. 2017;25:1797–1803.
    1. Kurtz S.M., Ong K.L., Lau E., Bozic K.J. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am. 2014;96:624–630.
    1. American Joint Replacement Registry (AJRR) American Academy of Orthopaedic Surgeons (AAOS); Rosemont, IL: 2019. 2019 Annual Report.
    1. Iorio R., Davis C.M., 3rd, Healy W.L., Fehring T.K., O'Connor M.I., York S. Impact of the economic downturn on adult reconstruction surgery: a survey of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2010;25:1005–1014.
    1. AAHS Members Survey on COVID-19 Impact . American Association of Hip and Knee Surgeons; 2020. AAHKS Weekly News Update. [accessed 17.04.2020]

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren